Free Trial

KalVista Pharmaceuticals (KALV) SEC Filings & 10K Form

KalVista Pharmaceuticals logo
$15.39 -0.62 (-3.87%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$15.30 -0.10 (-0.62%)
As of 07/18/2025 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent KalVista Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/10/2025
7:50 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2025
7:56 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2025
3:27 PM
KalVista Pharmaceuticals (Filer)
Form 424B5
07/10/2025
6:13 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025
7:39 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
6:27 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
6:28 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
6:28 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
10:44 AM
Capital World Investors (Filed by)
KalVista Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/11/2025
4:22 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
6:30 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:31 PM
KalVista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/10/2025
5:43 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:35 PM
KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:36 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:36 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:37 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:46 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:46 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:47 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
6:45 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
6:51 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:43 PM
KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/03/2025
6:39 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/03/2025
6:42 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
3:57 PM
KalVista Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/16/2024
6:07 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:08 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:17 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:07 PM
KalVista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/27/2024
7:43 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
7:45 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
3:41 PM
KalVista Pharmaceuticals (Issuer)
Reid Laurence (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
6:06 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2024
6:18 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
6:18 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
6:19 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
11:54 AM
Capital World Investors (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G
11/12/2024
8:31 AM
Adage Capital Management, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
1:34 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13D/A
11/04/2024
3:40 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The big winner of Crypto week? (Ad)

It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bitcoin hitting $123,000 and giants like BlackRock and Fidelity pouring in, one expert believes a lesser-known coin could soon be vaulted to the top — possibly even landing in the government’s digital reserve.

See the coin positioned to win from Washington’s crypto push
11/04/2024
11:00 AM
KalVista Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
6:00 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:05 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:06 PM
KalVista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:07 PM
KalVista Pharmaceuticals (Issuer)
Treanor Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:07 PM
KalVista Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:08 PM
KalVista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:08 PM
Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:32 PM
KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2024
3:34 PM
KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
7:31 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:39 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:24 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:07 PM
KalVista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/26/2024
6:58 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
7:00 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:13 PM
KalVista Pharmaceuticals (Filer)
Form DEFA14A
08/22/2024
3:17 PM
KalVista Pharmaceuticals (Filer)
Form ARS
08/22/2024
3:08 PM
KalVista Pharmaceuticals (Filer)
Form DEF 14A
08/21/2024
8:25 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
8:25 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
8:26 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:23 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2024
11:15 PM
KalVista Pharmaceuticals (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KALV) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners